Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals Statistics

Total Valuation

NSE:TORNTPHARM has a market cap or net worth of INR 1.52 trillion. The enterprise value is 1.74 trillion.

Market Cap	1.52T
Enterprise Value	1.74T

Important Dates

The last earnings date was Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	Feb 18, 2026

Share Statistics

Current Share Class	338.45M
Shares Outstanding	n/a
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	18.66%
Float	103.98M

Valuation Ratios

The trailing PE ratio is 70.16 and the forward PE ratio is 60.96.

PE Ratio	70.16
Forward PE	60.96
PS Ratio	10.86
PB Ratio	8.63
P/TBV Ratio	n/a
P/FCF Ratio	64.69
P/OCF Ratio	50.20
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 38.16, with an EV/FCF ratio of 74.15.

EV / Earnings	80.42
EV / Sales	12.44
EV / EBITDA	38.16
EV / EBIT	50.57
EV / FCF	74.15

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.85.

Current Ratio	1.13
Quick Ratio	0.61
Debt / Equity	0.85
Debt / EBITDA	3.30
Debt / FCF	6.40
Interest Coverage	8.94

Financial Efficiency

Return on equity (ROE) is 16.98% and return on invested capital (ROIC) is 12.48%.

Return on Equity (ROE)	16.98%
Return on Assets (ROA)	7.25%
Return on Invested Capital (ROIC)	12.48%
Return on Capital Employed (ROCE)	9.56%
Weighted Average Cost of Capital (WACC)	4.76%
Revenue Per Employee	8.20M
Profits Per Employee	1.27M
Employee Count	17,059
Asset Turnover	0.47
Inventory Turnover	1.19

Taxes

In the past 12 months, NSE:TORNTPHARM has paid 7.34 billion in taxes.

Income Tax	7.34B
Effective Tax Rate	25.56%

Stock Price Statistics

The stock price has increased by +36.73% in the last 52 weeks. The beta is 0.15, so NSE:TORNTPHARM's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+36.73%
50-Day Moving Average	4,262.95
200-Day Moving Average	3,907.01
Relative Strength Index (RSI)	61.90
Average Volume (20 Days)	281,501

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:TORNTPHARM had revenue of INR 139.80 billion and earned 21.63 billion in profits. Earnings per share was 63.92.

Revenue	139.80B
Gross Profit	105.92B
Operating Income	34.40B
Pretax Income	28.72B
Net Income	21.63B
EBITDA	45.59B
EBIT	34.40B
Earnings Per Share (EPS)	63.92

Balance Sheet

The company has 20.31 billion in cash and 150.25 billion in debt, with a net cash position of -129.94 billion.

Cash & Cash Equivalents	20.31B
Total Debt	150.25B
Net Cash	-129.94B
Net Cash Per Share	n/a
Equity (Book Value)	175.85B
Book Value Per Share	248.22
Working Capital	10.50B

Cash Flow

In the last 12 months, operating cash flow was 30.23 billion and capital expenditures -6.77 billion, giving a free cash flow of 23.46 billion.

Operating Cash Flow	30.23B
Capital Expenditures	-6.77B
Depreciation & Amortization	11.19B
Net Borrowing	118.67B
Free Cash Flow	23.46B
FCF Per Share	n/a

Margins

Gross margin is 75.77%, with operating and profit margins of 24.61% and 15.47%.

Gross Margin	75.77%
Operating Margin	24.61%
Pretax Margin	20.54%
Profit Margin	15.47%
EBITDA Margin	32.61%
EBIT Margin	24.61%
FCF Margin	16.78%

Dividends & Yields

This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.78%.

Dividend Per Share	35.00
Dividend Yield	0.78%
Dividend Growth (YoY)	9.38%
Years of Dividend Growth	2
Payout Ratio	59.59%
Buyback Yield	0.02%
Shareholder Yield	0.79%
Earnings Yield	1.43%
FCF Yield	1.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.

Last Split Date	Jul 8, 2022
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	4